Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts (Q36617852)

15 August 2017

Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts (English)

1 reference

15 August 2017

1 reference

4

Ellis IO

1 reference

15 August 2017

Jacobs E

1

1 reference

15 August 2017

Watson SA

series ordinal

2

1 reference

15 August 2017

Michaeli D

series ordinal

3

1 reference

15 August 2017

Robertson JF

series ordinal

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

80

1 reference

15 August 2017

3-4

1 reference

15 August 2017

352-359

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6690362

15 August 2017

0 references

cites work

A computer program for comparing K samples with right-censored data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362318

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362318

Estradiol-stimulated growth of MCF-7 tumors implanted in athymic mice: a model to study the tumoristatic action of tamoxifen

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362318

Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362318

Goserelin depot in the treatment of premenopausal advanced breast cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362318

Oestrogen and progesterone receptors in gastrointestinal cancer cell lines.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362318

Regulation of progesterone receptor gene expression and growth in the rat uterus: modulation of estrogen actions by progesterone and sex steroid hormone antagonists.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362318

Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route

20 September 2018

1 reference

12 December 2020

Effect of LHRH agonist, Zoladex, on ovarian histology

1 reference

12 December 2020

Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH

1 reference

12 December 2020

A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples

1 reference

12 December 2020

Immunoneutralisation of gonadotrophin releasing hormone: a potential treatment for oestrogen-dependent breast cancer

1 reference

12 December 2020

Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6690362

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

1 reference